Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ketamine Infusion Centers is a U.S. healthcare services company that operates ketamine infusion treatment clinics rather than a traditional drug-development biotech. The company provides physician-supervised intravenous ketamine treatments for mental health and pain-related conditions, with historical clinic operations in Phoenix, Arizona and Bakersfield, California. It was founded as Ketamine Infusion Centers LLC in Arizona and later acquired by Delic in 2021. The business appears to have generated commercial clinical revenue from patient treatments and is best categorized as a specialty care clinic operator in the psychedelic-adjacent mental health and infusion therapy space. It does not appear to have a proprietary drug pipeline or platform technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ketamine Infusion Centers.